"Among dialysis patients with osteoporosis, denosumab may be more effective than oral bisphosphonates in reducing fracture ...

A research team led by Matthew Nystoriak, Ph.D., associate professor of biomedical research and translational medicine at ...

For patients with acute myocardial infarction (MI) and anemia, the primary outcome of 30-day mortality or MI does not d ...

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

The Health Insurance Corp. (PhilHealth), which is not getting any subsidy from the government this year, has proceeded with ...

KIMSHEALTH surgeons repair rare Left Ventricular Pseudoaneurysm, saving patient's life in successful five-hour surgery.

Trientine hydrochloride is under clinical development by Innolife and currently in Phase I for Amyloidosis. According to GlobalData, Phase I drugs for Amyloidosis have a 91% phase transition success ...

CU-06 is under development for the treatment of diabetic macular edema, wet macular degeneration, ulcerative colitis and colon cancer. It is administered through oral route. The drug candidate acts by ...

Too many people still miss heart trouble Is your heart healthy? In a 2015 study published in JAMA, eight out of 10 men and ...

Australia: A new analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial has revealed that older patients ...

PhilHealth has significantly increased its coverage for Ischemic Heart Disease-Acute Myocardial Infarction (IHD-AMI) or ...

Costs related to cardiovascular health care represent a high burden and have been trending upward the past several years in ...